Report Categories
View AllRecent Articles
View All
Halozyme Therapeutics HALO Stock Analysis 302 Loss Key Levels 20260515
Short Sellers Circle the AI Sector How Hedge Funds Are Targeting Overhyped Tech Stocks
Jury Dismisses Elon Musks Lawsuit Against OpenAI and Sam Altman
TransCode Therapeutics RNAZ Q4 2024 Results Miss Estimates EPS 15064 vs 9168
MFS MCR Steady at 603 Awaiting Next Catalyst 20260514
Oxford OXLCN Stock Steady at 2491 Support at 2366 20260514
Fitness App Revolution Can Apps Replace Personal Trainers Market Implications Analyzed
EuroDry EDRY Stock Analysis 421 Loss Key Levels 20260517
Algonquin Power Utilities AQN Declines 125 as Selling Pressure Persists Near Key Support
Kayne Anderson BDC Inc KBDC Advances 13 Approaches Key Resistance Zone
Jackson Acquisition Company II JACS Holds Steady at 1061 Amid Narrow Trading Range
Calamos Convertible and High Income Fund CHY Nears Key Support After Minimal Change
REVB Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Awaits Clinical Milestones
Tesla Rolls Out Full SelfDriving Supervised in China After Years of Regulatory Delays
EXOD Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Revenue Disclosures
i80 Gold Corp IAUX Q1 2026 Earnings NarrowerThanExpected Loss Signals Progress for Gold Developer
Glenmark Pharma and Manappuram Finance Among ShortTerm Opportunities Identified by Religare Broking
Barclays Raises Price Target on JFrog to 75 Maintains Overweight Rating